International Team of Experts Joins Biorez Scientific Advisory Board
(November 2017) Leading Researchers and Surgeons to Advise Regenerative Medicine Company that Aims to Reinvent ACL Reconstruction Surgery
Paul Hermes Joins Biorez Board of Directors
(September 2017) Veteran Medical Device Executive Joins Regenerative Medicine Company as it Aims to Replace Autografts and Allografts with its Bioresorbable Scaffold Technology
Soft Tissue Regeneration Raises Series C Financing and Rebrands to Biorez
(March 2017) Based on results from our first-in-human study, we recently raised new financing to advance this promising technology.